Encyclopedia of Metalloproteins

2013 Edition
| Editors: Robert H. Kretsinger, Vladimir N. Uversky, Eugene A. Permyakov

Silver, Neurotoxicity

  • Hari Shanker Sharma
  • Aruna Sharma
Reference work entry
DOI: https://doi.org/10.1007/978-1-4614-1533-6_551
This is a preview of subscription content, log in to check access.

Notes

Acknowledgments

This investigation is partially supported by the Air Force Office of Scientific Research (London), Air Force Material Command, USAF, under grant number FA8655-05-1-3065. The US government is authorized to reproduce and distribute reprints for government purpose notwithstanding any copyright notation thereon. The views and conclusions contained herein are those of the authors and should not be interpreted as necessarily representing the official policies or endorsements, either expressed or implied, of the Air Force Office of Scientific Research or the US Government. We express sincere gratitude to several laboratories where a part of the work was done or some data was recorded and evaluated. Financial support from Swedish Medical Research Council (Grant Nr. 2710, HSS); Astra-Zeneca, Mölndal, Sweden (HSS), Alexander von Humboldt Foundation, Germany (HSS); IPSEN Medical, France (HSS); Ever NeuroPharma, Austria (AS); University Grants Commission, New Delhi, India (HSS); Indian Council of Medical Research, New Delhi, India (HSS/AS), is gratefully acknowledged. The authors have no conflict of interest with any of the financial agencies mentioned above.

References

  1. Agency for Toxic Substances and Disease Registry (ATSDR) (1990) Toxicological profile for silver. U.S. Department of Health and Human Services, Public Health Service, Atlanta, GA. http://www.atsdr.cdc.gov/toxprofiles/tp.asp?id=539%26tid=97. Accessed 30 June 2012
  2. Bouwmeester H, Poortman J, Peters RJ, Wijma E, Kramer E, Makama S, Puspitaninganindita K, Marvin HJ, Peijnenburg AA, Hendriksen PJ (2011) Characterization of translocation of silver nanoparticles and effects on whole-genome gene expression using an in vitro intestinal epithelium coculture model. ACS Nano 5(5):4091–4103CrossRefPubMedGoogle Scholar
  3. Calabrese V, Mancuso C, Calvani M, Rizzarelli E, Butterfield DA, Stella AM (2007) Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity. Nat Rev Neurosci 8(10):766–775CrossRefPubMedGoogle Scholar
  4. Cervós-Navarro J, Sharma HS, Westman J, Bongcam-Rudloff E (1998) Glial reactions in the central nervous system following heat stress. Prog Brain Res 115:241–274, ReviewCrossRefPubMedGoogle Scholar
  5. Chan SH, Chang KF, Ou CC, Chan JY (2004) Nitric oxide regulates c-fos expression in nucleus tractus solitarii induced by baroreceptor activation via cGMP-dependent protein kinase and cAMP response element-binding protein phosphorylation. MolPharmacol 65(2):319–325Google Scholar
  6. Chang CC, Tsai SS, Ho SC, Yang CY (2005) Air pollution and hospital admissions for cardiovascular disease in Taipei, Taiwan. Environ Res 98:114–119CrossRefPubMedGoogle Scholar
  7. Chen X, Schluesener HJ (2008) Nanosilver: a nanoproduct in medical application. Toxicol Lett 176(1):1–12, Epub 2007 Oct 16. ReviewCrossRefPubMedGoogle Scholar
  8. Elder A, Gelein R, Silva V, Feikert T, Opanashuk L, Carter J, Potter R, Maynard A, Ito Y, Finkelstein J, Oberdorster G (2006) Translocation of inhaled ultrafine manganese oxide particles to the central nervous system. Environ Health Perspect 114(8):1172–1178CrossRefPubMedGoogle Scholar
  9. Givogri MI, Bongarzone ER, Campagnoni AT (2000) New insights on the biology of myelin basic protein gene: the neural-immune connection. J Neurosci Res 59(2):153–159CrossRefPubMedGoogle Scholar
  10. Hughes P, Dragunow M (1995) Induction of immediate-early genes and the control of neurotransmitter-regulated gene expression within the nervous system. Pharmacol Rev 47(1):133–178PubMedGoogle Scholar
  11. Kim YS, Song MY, Park JD, Song KS, Ryu HR, Chung YH, Chang HK, Lee JH, Oh KH, Kelman BJ, Hwang IK, Yu IJ (2010) Subchronic oral toxicity of silver nanoparticles. Part Fibre Toxicol 7:20CrossRefPubMedGoogle Scholar
  12. Kruszewski M, Brzoska K, Brunborg G, Asare N, Dobrzyńska M, D_usinská M, Fjellsbø LM, Georgantzopoulou A, Gromadzka-Ostrowska J, Gutleb AC, Lankoff A, Magdolenová Z, Pran ER, Rinna A, Instanes C, Sandberg W, Schwarze P, Stępkowski T, Wojewódzka M, Refsnes M (2011) Toxicity of silver nanomaterials in highereukaryotes. In: Fishbein JC (ed) Advances in molecular toxicology, vol 5. Elsevier, Amsterdam, pp 179–218Google Scholar
  13. Lafuente JV, Sharma A, Patnaik R, Muresanu DF, Sharma HS (2012) Diabetes exacerbates nanoparticles inducedbrainpathology. CNS Neurol Disord Drug Targets 11(1):26–39CrossRefPubMedGoogle Scholar
  14. Landas S, Fischer J, Wilkin LD, Mitchell LD, Johnson AK, Turner JW, Theriac M, Moore KC (1985) Demonstration of regional blood–brain barrier permeability in human brain. Neurosci Lett 57(3):251–256CrossRefPubMedGoogle Scholar
  15. Lankveld DP, Oomen AG, Krystek P, Neigh A, Troost-de Jong A, Noorlander CW, Van Eijkeren JC, Geertsma RE, De Jong WH (2010) The kinetics of the tissue distribution of silver nanoparticles of different sizes. Biomaterials 31(32):8350–61CrossRefPubMedGoogle Scholar
  16. Loeschner K, Hadrup N, Qvortrup K, Larsen A, Gao X, Vogel U, Mortensen A, Lam HR, Larsen EH (2011) Distribution of silver in rats following 28 days of repeated oral exposure to silver nanoparticles or silveracetate. Part Fibre Toxicol 8:18CrossRefPubMedGoogle Scholar
  17. Menon PK, Muresanu DF, Sharma A, Mössler H, Sharma HS (2012) Cerebrolysin, a mixture of neurotrophic factorsinducesmarked neuroprotection in spinal cord injuryfollowingintoxication of engineered nanoparticles from metals. CNS Neurol Disord Drug Targets 11(1):40–49CrossRefPubMedGoogle Scholar
  18. Muresanu DF, Sharma HS (2007) Chronic hypertension aggravates heat stress induced cognitive dysfunction and brainpathology: an experimental study in the rat, using growth hormone therapy for possible neuroprotection. Ann N Y Acad Sci 1122:1–22CrossRefPubMedGoogle Scholar
  19. Muresanu DF, Sharma A, Sharma HS (2010) Diabetes aggravates heat stress-induced blood-brain barrier breakdown, reduction in cerebral bloodflow, edema formation, and brain pathology: possible neuroprotection with growth hormone. Ann N Y Acad Sci 1199:15–26CrossRefPubMedGoogle Scholar
  20. Muresanu DF, Sharma A, Tian ZR, Smith MA, Sharma HS (2012) Nanowired drug delivery of antioxidant compound H-290/51 enhances neuroprotection in hyperthermia-induced neurotoxicity. CNS Neurol Disord Drug Targets 11(1):50–64CrossRefPubMedGoogle Scholar
  21. Oberdorster G (1996) Significance of particle parameters in the evaluation of exposure-dose–response relationships of inhaled particles. Inhal Toxicol 8(Suppl):73–89PubMedGoogle Scholar
  22. Oberdorster G, Maynard A, Donaldson K, Castranova V, Fitzpatrick J, Ausman K, Carter J, Karn B, Kreyling W, Lai D, Olin S, Monteiro-Riviere N, Warheit D, Yang H, ILSI Research Foundation/Risk Science Institute Nanomaterial Toxicity Screening Working Group (2005) Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part Fibre Toxicol 2:8CrossRefPubMedGoogle Scholar
  23. Powers CM (2010) Developmental neurotoxicity of silver and silver nanoparticles modeled in vitro and in vivo. PhD thesis, Duke University, DurhamGoogle Scholar
  24. Rapoport SI (1976) Blood–brain barrier in physiology and medicine. Raven, New YorkGoogle Scholar
  25. Rungby J, Danscher G (1983) Neuronalaccumulation of silver in brains of progeny from argyric rats. Acta Neuropathol 61(3–4):258–262CrossRefPubMedGoogle Scholar
  26. Rungby J, Danscher G (1984) Hypoactivity in silver exposedmice. Acta PharmacolToxicol (Copenh) 55(5):398–401CrossRefGoogle Scholar
  27. Samuel U, Guggenbichler JP (2004) Prevention of catheter-related infections: the potential of a new nano-silver impregnated catheter. Int J Antimicrob Agents 23(Suppl 1):S75–S78CrossRefPubMedGoogle Scholar
  28. Sharma HS (1982) Blood–brain barrier in stress. PhD thesis, Banaras Hindu University, Varanasi, pp 1–85Google Scholar
  29. Sharma HS (1999) Pathophysiology of blood–brain barrier, brain edema and cell injury following hyperthermia: new role of heat shock protein, nitric oxide and carbon monoxide. An experimental study in the rat using light and electron microscopy. Acta Universitatis Upsaliensis 830:1–94Google Scholar
  30. Sharma HS (2004) Blood–brain and spinal cord barriers in stress. In: Sharma HS, Westman J (eds) The blood-spinal cord and brain barriers in health and disease. Elsevier/Academic, San Diego, pp 231–298CrossRefGoogle Scholar
  31. Sharma HS (2004a) Pathophysiology of the blood – spinal cord barrier in traumatic injury. In: Sharma HS, Westman J (eds) Blood – spinal cord and brain barriers in health & disease, Elsevier,/Academic Press, Oxford/Boston/San Diego, pp. 437–518CrossRefGoogle Scholar
  32. Sharma HS (2005a) Heat-related deaths are largely due to brain damage. Indian J Med Res 121(5):621–623PubMedGoogle Scholar
  33. Sharma HS (2005b) Selective neuronal vulnerability, blood–brain barrier disruption and heat shock protein expression in stress induced neurodegeneration. Invited review. In: Sarbadhikari SN (ed) Depression and Dementia: progress in brain research, clinical applications and future trends. Nova Science Publishers, New York, pp 97–152Google Scholar
  34. Sharma HS (2006a) Hyperthermia induced brain oedema: current status and future perspectives. Indian J Med Res 123(5):629–652PubMedGoogle Scholar
  35. Sharma HS (2006b) Hyperthermia influences excitatory and inhibitory amino acid neurotransmitters in the central nervous system. An experimental study in the rat using behavioural, biochemical, pharmacological, and morphological approaches. J Neural Transm 113(4):497–519CrossRefPubMedGoogle Scholar
  36. Sharma HS, Ali SF, Dong W, Tian ZR, Patnaik R, Patnaik S, Sharma A, Boman A, Lek P, Seifert E, Lundstedt T (2007) Drug delivery to the spinal cord tagged with nanowire enhances neuroprotective efficacy and functional recovery following trauma to the rat spinal cord. Ann N Y Acad Sci 1122:197–218CrossRefPubMedGoogle Scholar
  37. Sharma HS (2009a) Blood–central nervous system barriers: the gateway to neurodegeneration, neuroprotection and neuroregeneration. In: Lajtha A, Banik N, Ray SK (eds) Handbook of neurochemistry and molecular neurobiology: brain and spinal cord trauma. Springer, Berlin/Heidelberg/New York, pp 363–457CrossRefGoogle Scholar
  38. Sharma HS (2009b) Nanoneuroscience and Nanoneuropharmacology. Prog Brain Res 180:1–286Google Scholar
  39. Sharma HS (2012) New perspectives of central nervous system injury and neuroprotection. Int Rev Neurobiol 102:1–395CrossRefGoogle Scholar
  40. Sharma HS, Alm P (2004) Role of nitricoxide on the blood–brain and the spinal cord barriers. In: Sharma HS, Westman J (eds) The blood-spinal cord and brain barriers in health and disease. Elsevier/Academic, San Diego, pp 191–230CrossRefGoogle Scholar
  41. Sharma HS, Hoopes PJ (2003) Hyperthermiainduced pathophysiology of the central nervous system. Int J Hyperthermia 19(3):325–354, ReviewCrossRefPubMedGoogle Scholar
  42. Sharma HS, Johanson CE (2007a) Intracerebroventricularly administered neurotrophins attenuate blood cerebrospinal fluid barrier breakdown and brain pathology following whole-body hyperthermia: an experimental study in the rat using biochemical and morphological approaches. Ann N Y Acad Sci 1122:112–129CrossRefPubMedGoogle Scholar
  43. Sharma HS, Johanson CE (2007b) Blood-cerebrospinal fluid barrier in hyperthermia. Prog Brain Res 162:459–478, ReviewCrossRefPubMedGoogle Scholar
  44. Sharma HS, Sharma A (2007) Nanoparticles aggravate heat stress induced cognitive deficits, blood–brain barrier disruption, edema formation and brain pathology. Prog Brain Res 162:245–273, ReviewCrossRefPubMedGoogle Scholar
  45. Sharma HS, Sharma A (2010) Breakdown of the blood–brain barrier in stress alters cognitive dysfunction and induces brain pathology. New perspective for neuroprotective strategies. In: Ritsner M (ed) Brain protection in Schizophrenia, mood and cognitive disorders. Springer, Berlin/New York, pp 243–304CrossRefGoogle Scholar
  46. Sharma HS, Sharma A (2011) New strategies for CNS injury and repair using stem cells, nanomedicine, neurotrophic factors and novel neuroprotective agents. Expert Rev Neurother 11(8):1121–1124CrossRefPubMedGoogle Scholar
  47. Sharma HS, Sharma A (2012a) Neurotoxicity of engineered nanoparticles from metals. CNS Neurol Disord Drug Targets 11(1):65–80CrossRefPubMedGoogle Scholar
  48. Sharma HS, Sharma A (2012b) Nanowired drugdelivery for neuroprotection in central nervous system injuries: modulation by environmental temperature, intoxication of nanoparticles, and comorbidity factors. Wiley Interdiscip Rev Nanomed Nanobiotechnol 4(2):184–203CrossRefPubMedGoogle Scholar
  49. Sharma HS, Sharma A (2012c) Recent perspectives on nanoneuroprotection & nanoneurotoxicity. CNS Neurol Disord Drug Targets 11(1):5–6CrossRefPubMedGoogle Scholar
  50. Sharma HS, Westman J (2004a) The blood-spinal cord and brain barriers in health and disease. Academic, San Diego, pp 1–617 (Release date: Nov. 9, 2003)Google Scholar
  51. Sharma HS, Westman J (2004b) The heat shock proteins and hemeoxygenase response in central nervous system injuries. In: Sharma HS, Westman J (eds) The blood-spinal cord and brain barriers in health and disease. Elsevier/Academic, San Diego, pp 329–360CrossRefGoogle Scholar
  52. Sharma HS, Westman J, Nyberg F (1998a) Pathophysiology of brain edema and cell changes following hyperthermic brain injury. In: Sharma HS, Westman J (eds) Brain functions in hot environment. Progr Brain Res, 115:351–412Google Scholar
  53. Sharma HS, Alm P, Westman J (1998b) Nitricoxide and carbonmonoxide in the brain pathology of heat stress. Prog Brain Res 115:297–333, ReviewCrossRefPubMedGoogle Scholar
  54. Sharma HS, Ali SF, Tian ZR, Hussain SM, Schlager JJ, Sjöquist PO, Sharma A, Muresanu DF (2009a) Chronic treatment with nanoparticles exacerbate hyperthermia induced blood–brain barrier breakdown, cognitive dysfunction and brain pathology in the rat. Neuroprotective effects of nanowired-antioxidant compound H-290/51. J Nanosci Nanotechnol 9(8):5073–5090CrossRefPubMedGoogle Scholar
  55. Sharma HS, Ali SF, Hussain SM, Schlager JJ, Sharma A (2009b) Influence of engineered nanoparticles from metals on the blood–brain barrier permeability, cerebral blood flow, brain edema and neurotoxicity. An experimental study in the rat and mice using biochemical and morphological approaches. J Nanosci Nanotechnol 9(8):5055–5072CrossRefPubMedGoogle Scholar
  56. Sharma HS, Patnaik R, Sharma A (2010) Diabetes aggravates nanoparticles induced breakdown of the blood-brainbarrier permeability, brain edema formation, alterations in cerebral bloodflow and neuronal injury. An experimental study using physiological and morphological investigations in the rat. J Nanosci Nanotechnol 10(12):7931–7945CrossRefPubMedGoogle Scholar
  57. Sharma HS, Muresanu DF, Patnaik R, Stan AD, Vacaras V, Perju-Dumbrav L, Alexandru B, Buzoianu A, Opincariu I, Menon PK, Sharma A (2011) Superior neuroprotective effects of cerebrolysin in heat stroke following chronic intoxication of Cu or Ag engineered nanoparticles. A comparative study with other neuroprotective agents using biochemical and morphological approaches in the rat. J Nanosci Nanotechnol 11(9):7549–7569CrossRefPubMedGoogle Scholar
  58. Sharma HS, Sharma A, Mössler H, Muresanu DF (2012a) Neuroprotective effects of cerebrolysin, a combination of different active fragments of neurotrophic factors and peptides on the whole body hyperthermia-inducedneurotoxicity: modulatoryroles of co-morbidityfactors and nanoparticleintoxication. Int Rev Neurobiol 102:249–276CrossRefPubMedGoogle Scholar
  59. Sharma HS, Castellani RJ, Smith MA, Sharma A (2012b) The blood–brain barrier in Alzheimer’s disease: noveltherapeutic targets and nanodrug delivery. Int Rev Neurobiol 102:47–90CrossRefPubMedGoogle Scholar
  60. Sharma A, Muresanu DF, Mössler H, Sharma HS (2012c) Superior neuroprotective effects of cerebrolysin in nanoparticle-induced exacerbation of hyperthermia-induced brain pathology. CNS Neurol Disord Drug Targets 11(1):7–25CrossRefPubMedGoogle Scholar
  61. Stalberg E, Sharma H, Sharma HS, Olsson Y (1998) Spinal cord monitoring. Basic principles, regeneration, pathophysiology and clinical aspects. Springer, Wien/New York, pp 1–525CrossRefGoogle Scholar
  62. Takenaka S, Karg E, Roth C, Schulz H, Ziesenis A, Heinzmann U, Schramel P, Heyder J (2001) Pulmonary and systemic distribution of inhaled ultrafine silver particles in rats. Environ Health Perspect 109(Suppl 4):547–551PubMedGoogle Scholar
  63. Takenaka K, Saidoh N, Nishiyama N, Inoue A (2011) Fabrication and nano-imprintabilities of Zr-, Pd- and Cu-based glassy alloy thin films. Nanotechnology 22(10):105302CrossRefPubMedGoogle Scholar
  64. Thilagavathi G, Raja ASM, Kannaian T (2008) Nanotechnology and protective clothing for defence personnel. Def Sci J 58(4):451–459Google Scholar
  65. Westman J, Sharma HS (1998) Heat shock protein response in the central nervous system followinghyperthermia. Prog Brain Res 115:207–239, ReviewCrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Laboratory of Cerebrovascular Research, Department of Surgical Sciences, Anesthesiology & Intensive Care medicineUniversity Hospital, Uppsala UniversityUppsalaSweden